August 21, 2020
Genentech is letting go 474 staffers on the West Coast. Most of the 474 employees will be gone by September 18, with all gone by October. […]
August 21, 2020
Biogen plans to spend more than $1B to access experimental Parkinson’s disease drugs and take an equity stake in their developer, Denali Therapeutics. Denali’s most advanced […]
August 21, 2020
So far this year, U.S.-listed biotech companies have raised roughly $9.4 billion in initial public offerings, already beating the $6.5 billion raised in all of 2018, […]
August 21, 2020
Johnson & Johnson has struck a deal to buy Momenta Pharmaceuticals for $6.5B, giving J&J control of an anti-FcRn antibody that completed a phase 2 trial […]
August 21, 2020
While Biogen’s top products are facing tough competition and the biotech is trying to secure approval for what could be a first-of-its-kind Alzheimer’s disease drug, the […]
August 28, 2020
Earlier this month, Regeneron and Roche made a manufacturing pact to triple production of a COVID-19 antibody cocktail. Those plans have made it difficult for Regeneron […]
September 4, 2020
The U.S. government is buying almost all of the $5 Covid tests Abbott Laboratories plans to produce this year, purchasing 150 million of the tests that […]
September 11, 2020
Fierce 15 winner Prelude Therapeutics is going for a $100M IPO as it looks to finish off early clinical work for its cancer drug candidate PRT543. […]
September 18, 2020
Unity Biotechnology lost its lead anti-aging program last month after a Phase II flop. Now, 30% of its staff will be cut as the company restructures […]